Bioanalysis

BioAgilytix Holds Ribbon Cutting To Celebrate Boston Lab Expansion, Additional Jobs And Tech Capabilities

Retrieved on: 
Tuesday, June 8, 2021

BOSTON, June 8, 2021 /PRNewswire/ --BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, recently held a ribbon-cutting to celebrate the large-scale expansion of its leading-edge Boston laboratory.

Key Points: 
  • BOSTON, June 8, 2021 /PRNewswire/ --BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, recently held a ribbon-cutting to celebrate the large-scale expansion of its leading-edge Boston laboratory.
  • At the end of the day, together we focus our abilities on enabling the best possible clinical outcomes for patients."
  • With these expansions, BioAgilytix's Boston lab doubled its square footage as well as its employee base.
  • BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory.

Agilex Biolabs and Gyros Protein Technologies Partner for BioAnalysis Zone Webinar on Singlicate Analysis

Retrieved on: 
Monday, May 31, 2021

ADELAIDE, AUS, May 31, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Gyros Protein Technologies and BioAnalysis Zone to share the latest on singlicate analysis on the Gyrolab platform.

Key Points: 
  • ADELAIDE, AUS, May 31, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Gyros Protein Technologies and BioAnalysis Zone to share the latest on singlicate analysis on the Gyrolab platform.
  • Agilex Biolabs' Principal Method Development Scientist, Morgan Evans will present with Gyros Protein Technologies' Application & Service Director EMEA and Asia Pacific, John Chappell for a comprehensive webinar titled Singlicate analysis on the Gyrolab platform.
  • Over the last several years singlet analysis has become a hot topic within the world of LBA non-regulated and regulated bioanalysis.
  • This webinar will look at the overall landscape of singlet analysis and through Agilex Biolabs case studies discuss the use of the Gyrolab technology.

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials

Retrieved on: 
Friday, May 21, 2021

These immune cells boast elevated numbers and heightened activation as they churn out inflammatory mediators, which act in unison to coordinate and modulate the immune response.

Key Points: 
  • These immune cells boast elevated numbers and heightened activation as they churn out inflammatory mediators, which act in unison to coordinate and modulate the immune response.
  • Choosing the right bioanalytical platform for your immunology clinical trial is critical to data collection.
  • https://calendly.com/agilexbiolabs/15min\nAgilex Biolabs, Australia\'s leading bioanalytical laboratory, has more than 24 years\' experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services.
  • The company has recently expanded its main labs by more than 30% to accommodate biotech demand from APAC and the USA.

Labcorp to Expand Bioanalytical Services With Integrated Laboratory in Singapore

Retrieved on: 
Wednesday, May 19, 2021

\xe2\x80\x9cWe are thrilled to expand services in this area and enhance the options available to those we serve.

Key Points: 
  • \xe2\x80\x9cWe are thrilled to expand services in this area and enhance the options available to those we serve.
  • The new laboratory will provide expedited turnaround time for our clients and enhance Covance by Labcorp\xe2\x80\x99s ability to deliver for the Asia-Pacific region.\xe2\x80\x9d\nThe new bioanalytical laboratory in Singapore will support the development of both small and large molecular entities while providing a complete range of regulated and non-regulated bioanalytical services.
  • Bioanalytics is a quantitative measure of drugs and metabolites in biological samples such as blood, serum, tissue and plasma.
  • The laboratory will offer Good Laboratory Practice and Good Clinical Practice-compliant bioanalysis, liquid chromatography-mass spectometry and immunochemistry platforms, as well as discovery and clinical biomarker analytical services.

Agilex Biolabs' Toxicology Tapped for SARS-CoV-2 Vaccine Research

Retrieved on: 
Monday, May 17, 2021

"\nTetraQ non-GLP toxicology study results can be used to support the design of both key efficacy studies and formal GLP toxicology studies in rodents.

Key Points: 
  • "\nTetraQ non-GLP toxicology study results can be used to support the design of both key efficacy studies and formal GLP toxicology studies in rodents.
  • Formal GLP toxicity studies can in turn support first-in-human studies.
  • https://calendly.com/agilexbiolabs/15min\nAgilex Biolabs, Australia\'s leading bioanalytical and toxicology laboratory, has more than 24 years\' experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services.
  • The company has recently acquired TetraQ biolabs and toxicology, and also expanded its main labs by more than 30% to accommodate biotech demand from APAC and the USA.

Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results

Retrieved on: 
Friday, April 30, 2021

b'ADELAIDE, AUS, Apr 30, 2021 - (ACN Newswire) - Agilex Biolabs, Australia\'s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today congratulated client Bionomics Limited (Bionomics) on its positive pharmacokinetic (PK) results from a 7-day dosing study in healthy volunteers using the newly developed solid dose oral tablet formulation of BNC210.\nLiz Doolin, Bionomics\' Vice President Clinical Development commented that "We greatly value our long-standing partnership with Agilex Biolabs who continue to be a partner of choice for Bionomics and have supported the development of BNC210 from the beginning.

Key Points: 
  • b'ADELAIDE, AUS, Apr 30, 2021 - (ACN Newswire) - Agilex Biolabs, Australia\'s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today congratulated client Bionomics Limited (Bionomics) on its positive pharmacokinetic (PK) results from a 7-day dosing study in healthy volunteers using the newly developed solid dose oral tablet formulation of BNC210.\nLiz Doolin, Bionomics\' Vice President Clinical Development commented that "We greatly value our long-standing partnership with Agilex Biolabs who continue to be a partner of choice for Bionomics and have supported the development of BNC210 from the beginning.
  • "\nBionomics (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5), is a global, clinical stage biopharmaceutical company.
  • Agilex Biolabs has been working closely with Bionomics for several years, supporting the PK regulated Bioanalysis of BNC210 and is privileged to be a part of this potential new treatment for anxiety and stressor-related disorders.
  • Australian clinical trials have remained open for business and Agilex Biolabs is a designated essential service so clients can be assured of study continuity.

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

Retrieved on: 
Wednesday, April 28, 2021

Sales, Agilex Biolabs\' Director of Immunoassay, Ronald R. Bowsher PhD, Partner and Chief Scientific Officer at B2S Life Sciences, and Amy Rosen, Associate Director of Statistics at B2S.\nThe panel shared insights from many years working in immunoassay bioanalysis for clinical trials.

Key Points: 
  • Sales, Agilex Biolabs\' Director of Immunoassay, Ronald R. Bowsher PhD, Partner and Chief Scientific Officer at B2S Life Sciences, and Amy Rosen, Associate Director of Statistics at B2S.\nThe panel shared insights from many years working in immunoassay bioanalysis for clinical trials.
  • Ronald R. Bowsher said B2S has been working with Agilex Biolabs for more than four years, "Our relationship has evolved very well, and we understand each other\'s needs.
  • And despite the geographic differences, I think we\'ve had a very productive collaboration serving Agilex Biolabs\' customers," he said.\nDr Kurt J.
  • We offer services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.\n'

Comparison of Hybrid LCMS & Ligand Binding Assays for Bioanalysis, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, April 5, 2021

TORONTO, April 5, 2021 /PRNewswire-PRWeb/ -- Historically, bioanalytical support for large molecule development has utilized ligand binding (LBA) technologies.

Key Points: 
  • TORONTO, April 5, 2021 /PRNewswire-PRWeb/ -- Historically, bioanalytical support for large molecule development has utilized ligand binding (LBA) technologies.
  • Hybrid mass spectrometry only requires one reagent for enrichment and this reagent does not need to be extremely selective.
  • In the past, our ligand binding team provided the majority of our large molecule bioanalysis support.
  • For more information, or to register for this event, visit Comparison of Hybrid LCMS & Ligand Binding Assays for Bioanalysis.

Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021

Retrieved on: 
Wednesday, March 17, 2021

ADELAIDE, AU, Mar 17, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021.

Key Points: 
  • ADELAIDE, AU, Mar 17, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021.
  • Sales Agilex Biolabs' Director Immunoassay said:
    "Our experienced team can develop or transfer a method for any biologic to support pre-clinical GLP or clinical studies.
  • Agilex Biolabs also features a rebate of up to 43.5% on clinical trial bioanalytical services spend as part of the Australian Government clinical trial attraction program.
  • We offer services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.

Immunologix Laboratories Expands Translational Sciences Team

Retrieved on: 
Tuesday, February 16, 2021

TAMPA, Fla., Feb. 16, 2021 /PRNewswire/ -- Immunologix Laboratories announces two additions to the Translational Sciences division with Corinna Fiorotti, Ph.D .

Key Points: 
  • TAMPA, Fla., Feb. 16, 2021 /PRNewswire/ -- Immunologix Laboratories announces two additions to the Translational Sciences division with Corinna Fiorotti, Ph.D .
  • The continued growth of Translational Sciences highlights Immunologix Laboratories' commitment to building an unparalleled model of scientific partnership with our clients.
  • At Immunologix, she will build on that experience to lead project management, business operations and scientific content development efforts for the Translational Sciences team.
  • Immunologix Laboratories is a unique scientific partner, offering GLP and GCP compliant laboratory capabilities focused on ligand binding based bioanalysis and expert scientific consultation from our Translational Sciences team.